HMGCR and cancer: Moreover, observations from preclinical studies and clinical meta-analysis showed that the potent activity of statins, which inhibit the flux-initiating enzyme HMG-CoA reductase of the MEV pathway, could suppress the survival of cancer cells by inducing growth arrest and apoptosis [19,23].